Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice
Association of Surgeons in Training, Association of Surgeons of Great Britain and Ireland, The Association of Coloproctology of Great Britain and Ireland (ACPGBI), The Royal College of Surgeons of England, Royal College of Surgeons in Ireland (RCSI), The Royal College of Surgeons of Edinburgh Manchester Cancer Research Centre Dr
These therapeutic agents contribute to improvements in key cardiovascular risk factors, including reductions in body weight, blood pressure, and glycaemic variability, all of which are independently associated with decreased cardiovascular risk [4, 5]
Liraglutide, a once-daily human GLP-1 analogue, provides sustained improvements in glycaemic control and weight for two years as monotherapy compared with glimepiride in patients with type 2 diabetes
Vomiting within two hours of taking an OC can eject the tablet before meaningful absorption occurs